Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,976 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01127555 | Salvage mFOLFOX in BTC After Failure of Gemcitabine | completed | Phase 2 | 30 | Chung-Ang UniversityOTHER | 1 | Oct 8, 2013 | clinicaltrials |
| NCT01231581 | Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer | completed | Phase 2 | 160 | GlaxoSmithKlineINDUSTRY | 2 | Sep 26, 2013 | clinicaltrials |
| NCT01204177 |
| Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer.(BASIL) |
| completed |
| Phase 2 |
| 70 |
| BayerINDUSTRY |
| 4 |
| Sep 6, 2013 |
| clinicaltrials |
| NCT01923935 | Busulfan and Melphalan Conditioning in Multiple Myeloma | unknown | Phase 2 | 105 | Chonnam National University HospitalOTHER | 1 | Aug 19, 2013 | clinicaltrials |
| NCT00398385 | Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer | unknown | Phase 2 | 170 | National Cancer Center, KoreaOTHER_GOV | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00886717 | Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer | unknown | Phase 1 / Phase 2 | 74 | Asan Medical CenterOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01118845 | Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma | completed | Phase 2 | 63 | SymBio PharmaceuticalsINDUSTRY | 2 | Jul 4, 2013 | clinicaltrials |
| NCT00452634 | Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) | completed | Phase 2 | 62 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00620347 | Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer | completed | Phase 2 | 25 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00743678 | Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis | completed | Phase 2 | 73 | Samsung Medical CenterOTHER | 1 | Jun 14, 2013 | clinicaltrials |
| NCT01106066 | Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT | terminated | Phase 1 / Phase 2 | 30 | Samsung Medical CenterOTHER | 1 | Jun 14, 2013 | clinicaltrials |
| NCT01281761 | Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC) | completed | Phase 2 | 52 | Samsung Medical CenterOTHER | 1 | Jun 14, 2013 | clinicaltrials |
| NCT01871688 | Pelvic Floor Rehabilitation for Gynecological Cancer Patients | unknown | Phase 2 / Phase 3 | 100 | Seoul National University Bundang HospitalOTHER | 1 | Jun 7, 2013 | clinicaltrials |
| NCT01130753 | Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer | completed | Phase 2 | 43 | Samsung Medical CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT01861197 | Phase II Study of Dovitinib for FGFR1 Amplified Squamous Non-small Cell Lung Cancer | unknown | Phase 2 | 27 | Samsung Medical CenterOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT01856452 | Comparison Study of Sentinel Lymph Node Biopsy by Multimodal Method in Breast Cancer | completed | Phase 2 | 86 | National Cancer Center, KoreaOTHER_GOV | 1 | May 17, 2013 | clinicaltrials |
| NCT00062257 | Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer | completed | Phase 2 | — | Cancer Therapeutics Research GroupOTHER | 4 | May 15, 2013 | clinicaltrials |
| NCT00077415 | 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 31 | Cancer Therapeutics Research GroupOTHER | 4 | May 15, 2013 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT01851941 | A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer | completed | Phase 2 | 52 | Seoul National University HospitalOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT00818090 | Paclitaxel and Cisplatin for Thymic Neoplasm | terminated | Phase 2 | 39 | Korean Cancer Study GroupOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01830153 | RAD001 in Advanced Sarcoma | completed | Phase 2 | 41 | Asan Medical CenterOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01238055 | Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer | completed | Phase 2 | 116 | Samsung Medical CenterOTHER | 1 | Apr 9, 2013 | clinicaltrials |
| NCT01824004 | Postoperative Chemoradiotherapy With S-1 in Gastric Cancer | completed | Phase 2 | 46 | Chonnam National University HospitalOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00618501 | Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | completed | Phase 2 | 50 | Asan Medical CenterOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00627666 | Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer | completed | Phase 2 | 52 | Asan Medical CenterOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT01463059 | Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy | completed | Phase 2 | 119 | UCB Japan Co. Ltd.INDUSTRY | 3 | Mar 25, 2013 | clinicaltrials |
| NCT00494091 | Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma | completed | Phase 2 | 82 | PfizerINDUSTRY | 3 | Mar 21, 2013 | clinicaltrials |
| NCT00379574 | Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL | completed | Phase 1 / Phase 2 | 49 | Asan Medical CenterOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT00824746 | Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)(ReGaiN) | completed | Phase 2 | 23 | Chonnam National University HospitalOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT01659619 | Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis | completed | Phase 2 | 114 | The Catholic University of KoreaOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00823524 | Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | 47 | Asan Medical CenterOTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00550173 | A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer | completed | Phase 2 | 247 | Eli Lilly and CompanyINDUSTRY | 7 | Feb 13, 2013 | clinicaltrials |
| NCT00558103 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | completed | Phase 2 | 163 | GlaxoSmithKlineINDUSTRY | 28 | Feb 4, 2013 | clinicaltrials |
| NCT01196234 | Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer(PRIDE) | completed | Phase 2 | 84 | Asan Medical CenterOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT01510990 | First Line Gefitinib by FDG-PET Metabolic Response | unknown | Phase 2 | 60 | Asan Medical CenterOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT00378066 | Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer | completed | Phase 2 | 49 | Asan Medical CenterOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT01770795 | A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer | completed | Phase 2 | 45 | Gachon University Gil Medical CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00816543 | Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma | completed | Phase 2 | 41 | SanofiINDUSTRY | 1 | Dec 18, 2012 | clinicaltrials |
| NCT01737346 | Procarbazine and Lomustine in Recurrent Glioblastoma | unknown | Phase 2 | 52 | Incheon St.Mary's HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT00922896 | Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer | completed | Phase 2 | 22 | Gyeongsang National University HospitalOTHER | 1 | Nov 20, 2012 | clinicaltrials |
| NCT01676558 | A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) | unknown | Phase 2 | 24 | Korea Cancer Center HospitalOTHER | 1 | Nov 14, 2012 | clinicaltrials |
| NCT01234818 | Management of Endometrial Hyperplasia With a LNG-IUS: Multicenter Study: KGOG2006(KGOG2006) | unknown | Phase 2 | 80 | Korean Gynecologic Oncology GroupOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT01710956 | Once Daily Accelerated Fractionation With Concomitant Boost to the Gross Tumor Volume Compared With Twice Daily Hyperfractionation in Concurrent Chemoradiation in Patients With Limited Disease Small Cell Lung Cancer | unknown | Phase 2 | 84 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 19, 2012 | clinicaltrials |
| NCT01012336 | Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin | completed | Phase 2 | 89 | Samsung Medical CenterOTHER | 1 | Oct 10, 2012 | clinicaltrials |
| NCT01527877 | Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck | unknown | Phase 2 | 53 | Yonsei UniversityOTHER | 1 | Oct 8, 2012 | clinicaltrials |
| NCT00677144 | Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer | completed | Phase 2 | 88 | Hallym University Medical CenterOTHER | 1 | Oct 5, 2012 | clinicaltrials |
| NCT01054781 | Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL) | completed | Phase 2 | 91 | Samsung Medical CenterOTHER | 1 | Sep 27, 2012 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials